- Accelerates Perrigo's stated strategy to expand internationally and leverage its existing product portfolio - Combines Perrigo's supply chain and operational excellence with Omega's OTC branding and regulatory expertise
- Establishes broad global commercial presence and creates multiple opportunities to cross-sell Perrigo products in diverse new channels - Combined pro forma last twelve month revenue of $5.7 billion, further strengthens Perrigo's financial profile through geographic diversification of revenue and cash flow streams - Expected to be immediately accretive to adjusted EPS and double-digit accretion in fiscal year 2016 DUBLIN , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.